Are there different effects of acarbose and voglibose on serum levels of digoxin in a diabetic patient with congestive heart failure?

Nagai, Y; Hayakawa, T; Abe, T; Nomura, G

Nagai, Y; Hayakawa, T; Abe, T; Nomura, G.

Diabetes Care ; 23(11): 1703, 2000 Nov.

Article in En | MEDLINE | ID: mdl-11092296

Subject(s)

Acarbose/therapeutic use; Diabetes Mellitus, Type 2/drug therapy; Digoxin/blood; Heart Failure/drug therapy; Inositol/analogs & derivatives; Aged; Aged, 80 and over; Cardiotonic Agents/blood; Cardiotonic Agents/pharmacokinetics; Cardiotonic Agents/therapeutic use; Diabetes Mellitus, Type 2/blood; Diabetes Mellitus, Type 2/complications; Digoxin/pharmacokinetics; Digoxin/therapeutic use; Drug Interactions; Enzyme Inhibitors/therapeutic use; Glycoside Hydrolase Inhibitors; Heart Failure/blood; Heart Failure/complications; Humans; Hypoglycemic Agents/therapeutic use; Inositol/therapeutic use; Male

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia Main subject: Acarbose / Diabetes Mellitus, Type 2 / Digoxin / Heart Failure / Inositol Language: En Journal: Diabetes Care Year: 2000 Type: Article

Search on Google

Add to My VHL

XML

PubMed Links